# Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight

> **NCT00507949** · PHASE2 · COMPLETED · sponsor: **Rottapharm Spain** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Megestrol acetate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00507949
- **Lead sponsor:** Rottapharm Spain
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2009-04
- **Final completion:** 2009-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507949, "Study to Evaluate the Effect of Megestrol Acetate in Severe Chronic Obstructive Pulmonary Disease With Loss of Weight". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00507949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*